NSUN5 shows abnormal expression in various cancers, including gastric cancer, clear cell renal carcinoma, colorectal cancer, liver cancer, and head and neck squamous cell carcinoma, playing a key role in tumor initiation and progression. This evidence concerns the gene NSUN5 and clear cell renal carcinoma.